
Toni Pashley Joins Scene Health As Chief Product Officer To Help Solve The Medication Adherence Challenge
With a proven track record of developing large-scale integrated platforms in digital health, Pashley is set to elevate Scene Health's product to a new level of interoperability, scalability, and innovation. In this newly created role, Pashley will leverage her leadership experience to drive the product vision and market positioning for Scene Health, making Scene a change maker in virtual care with demonstrable and independently validated ROI. Pashley's experience in data analytics, engagement, and behavior change programs will add an increased focus on the patient experience and data insights offered by Scene Health.
“I'm excited to join Scene Health and use my health technology experience to solve complex challenges for clinical engagement across health plans, providers, and patients,” says Pashley.“I look forward to collaborating with the talented team at Scene Health to further the mission of driving real, tangible impact on people's health and the costs of healthcare. The distinctive video engagement capabilities offered by Scene present a compelling and novel opportunity while addressing a pressing need in healthcare.”
Pashley joins Scene Health from Sharecare, where she was the EVP & Chief Product Officer, helping grow the business and leading both product and engineering teams from startup to a publicly traded company. Her prior work across organizations like CNN, the CDC, NCR, and AT&T has equipped her with a unique understanding of the complexities of data integration and software development.
“Toni Pashley is a proven healthcare executive and leader, and we are very excited to have her on board. Her vision and commitment to rapid technological advancement make her the ideal leader for our team as we scale,” said Sebastian Seiguer, CEO of Scene Health.“When people with chronic conditions take their medication as prescribed, they get sick less often and stay out of the hospital. Toni will be instrumental in making our market-leading video Directly Observed Therapy (video DOT) solution available to more and more people who need support in taking medication as prescribed.” Scene's video DOT is the gold standard for medication adherence and has been integrated into CDC treatment guidelines. More than twenty-five peer-reviewed publications and customer studies demonstrate Scene's ability to help improve condition control and prevent hospitalization.
About Scene Health
Scene Health 's 360° model of care utilizes Directly Observed Therapy through video technology to address the $500B medication non-adherence problem. Scene currently delivers programs for government-sponsored health plans, public health departments, and life science organizations covering multiple chronic and infectious conditions, including diabetes, hypertension, asthma, CHF, cholesterol control, opioid use disorder, hepatitis C, tuberculosis, and solid organ transplant. For further information, please contact ...th.
A photo accompanying this announcement is available at


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- VUBE Exchange Announces Unified Account Integration Across VUBE Pro, VUBE Plus, And VUBE Max
- Fitell Corporation Launches Solana (SOL) Digital Asset Treasury With $100M Financing Facility, With Focus On Yield And On-Chain Defi Innovation
- Meanwhile, Bitcoin Life Insurer, Secures $82M To Meet Soaring Demand For Inflation-Proof Savings
- Edgen Launches Multi‐Agent Intelligence Upgrade To Unify Crypto And Equity Analysis
- The Bitcoin Way Launches Panama Discovery Trip - A Premium 3-Day Plan B Experience
- Seoul Exchange, One Of Only Two Licensed Platforms For Unlisted Securities, Will Exclusively Use Story To Settle Tokenized Rwas
Comments
No comment